Stonepine Capital Management, LLC
Position in PCSA — Processa Pharmaceuticals, Inc.
CIK 1440771
BEND, OR
Position in PCSA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$138,875
+$103,385 QoQ
Shares Held
55,000
+346.3% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2
of 10 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCSA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stonepine Capital Management, LLC holds $317,990,358 across 56 Biotechnology names. PCSA ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RADX |
Radiopharm Theranostics Ltd
|
51,000,000 | $219,300,000 | |
| 2 | VSTM |
Verastem, Inc.
|
3,302,300 | $17,502,190 | |
| 3 | TENX |
Tenax Therapeutics, Inc.
|
975,200 | $15,593,448 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
740,000 | $6,667,400 | |
| 5 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,128,233 | |
| 6 | NKTR |
Nektar Therapeutics
|
85,000 | $6,115,750 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
480,000 | $4,473,600 | |
| 8 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
383,462 | $3,600,708 |
All Filings in PCSA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $138,875 | 55,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $35,490 | 12,323 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||